Gemmer Asset Management LLC Bristol Myers Squibb CO Transaction History

Gemmer Asset Management LLC

$969 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $335 - $380	7 Added 0.14%	5,082 $275,000
Q4 2023 Jan 17, 2024	BUY	$48.48 - $57.85 $3,975 - $4,743	82 Added 1.64%	5,075 $260,000
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $6,020 - $6,731	104 Added 2.13%	4,993 $289,000
Q2 2023 Jul 19, 2023	SELL	$63.71 - $70.74 $147,552 - $163,833	-2,316 Reduced 32.14%	4,889 $312,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $4,008 - $4,546	61 Added 0.85%	7,205 $499,000
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $1,301 - $1,540	19 Added 0.27%	7,144 $0
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $19 - $11,295	147 Added 2.11%	7,125 $507,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $2,033 - $2,239	-28 Reduced 0.4%	6,978 $537,000
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $1,537 - $1,843	25 Added 0.36%	7,006 $511,000
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $2,413 - $2,813	45 Added 0.65%	6,981 $435,000
Q3 2021 Oct 19, 2021	SELL	$59.17 - $69.31 $6,922 - $8,109	-117 Reduced 1.66%	6,936 $410,000
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $3,405 - $3,708	55 Added 0.79%	7,053 $471,000
Q1 2021 Apr 20, 2021	BUY	$59.34 - $66.74 $129,598 - $145,760	2,184 Added 45.37%	6,998 $442,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $173 - $196	3 Added 0.06%	4,814 $299,000
Q3 2020 Oct 21, 2020	BUY	$57.43 - $63.64 $172 - $190	3 Added 0.06%	4,811 $290,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $2,960 - $3,460	54 Added 1.14%	4,808 $283,000
Q1 2020 May 01, 2020	SELL	$46.4 - $67.43 $5,289 - $7,687	-114 Reduced 2.34%	4,754 $264,000
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $10,383 - $13,544	211 Added 4.53%	4,868 $313,000
Q3 2019 Oct 11, 2019	SELL	$42.77 - $50.71 $18,733 - $22,210	-438 Reduced 8.6%	4,657 $236,000
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $45,244 - $50,030	1,014 Added 24.85%	5,095 $231,000
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $135 - $161	3 Added 0.07%	4,081 $195,000
Q4 2018 Jan 18, 2019	BUY	$48.76 - $63.23 $146 - $189	3 Added 0.07%	4,078 $212,000
Q3 2018 Oct 12, 2018	BUY	$55.19 - $62.25 $165 - $186	3 Added 0.07%	4,075 $253,000
Q2 2018 Jul 18, 2018	BUY	$50.53 - $62.98 $151 - $188	3 Added 0.07%	4,072 $225,000
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $17,856 - $20,556	-298 Reduced 6.82%	4,069 $257,000
Q4 2017 Jan 16, 2018	BUY	$59.94 - $65.35 $39,140 - $42,673	653 Added 17.58%	4,367 $268,000
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $205,124 - $236,730	3,714	3,714 $237,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.

Account